Drugs to treat diseases from cancer to AIDS could soon rely on short strands of RNA for their effects. But scientists must first work out how to navigate these fragments around the body. Nathan Blow reports.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Elbashir, S. M. et al. Nature 411, 494–498 (2001).
Soutschek, J. et al. Nature 432, 173–178 (2004).
Zimmermann, T. S. et al. Nature 441, 111–114 (2006).
Yang L., Bailey, L., Baltimore, D. & Wang, P. Proc. Natl Acad. Sci. USA 103, 11479–11484 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blow, N. Delivering the future. Nature 450, 1119–1120 (2007). https://doi.org/10.1038/4501117a
Published:
Issue date:
DOI: https://doi.org/10.1038/4501117a
This article is cited by
-
Personalized Cancer Approach: Using RNA Interference Technology
World Journal of Surgery (2011)
-
Octa-guanidine Morpholino Restores Dystrophin Expression in Cardiac and Skeletal Muscles and Ameliorates Pathology in Dystrophic mdx Mice
Molecular Therapy (2009)
-
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Nature Biotechnology (2009)
